Medicus Pharma Stock Price To Earnings To Growth
MDCX Stock | 3.95 0.25 6.76% |
Medicus Pharma fundamentals help investors to digest information that contributes to Medicus Pharma's financial success or failures. It also enables traders to predict the movement of Medicus Stock. The fundamental analysis module provides a way to measure Medicus Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medicus Pharma stock.
Medicus |
Medicus Pharma Company Price To Earnings To Growth Analysis
Medicus Pharma's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Based on the latest financial disclosure, Medicus Pharma has a Price To Earnings To Growth of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Price To Earnings To Growth (which currently averages 0.0) industry. This indicator is about the same for all Canada stocks average (which is currently at 0.0).
Medicus Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medicus Pharma's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medicus Pharma could also be used in its relative valuation, which is a method of valuing Medicus Pharma by comparing valuation metrics of similar companies.Medicus Pharma is currently under evaluation in price to earnings to growth category among its peers.
Medicus Fundamentals
Current Valuation | 39.65 M | |||
Shares Outstanding | 11.82 M | |||
Number Of Shares Shorted | 900 | |||
Price To Book | 9.45 X | |||
Net Income | (6.78 M) | |||
Total Debt | 1.09 M | |||
Cash Flow From Operations | (4.16 M) | |||
Short Ratio | 0.96 X | |||
Earnings Per Share | (1.25) X | |||
Target Price | 5.61 | |||
Market Capitalization | 46.68 M | |||
Total Asset | 1.89 M | |||
Retained Earnings | (19.18 M) | |||
Working Capital | 805.8 K | |||
Net Asset | 1.89 M |
About Medicus Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medicus Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicus Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicus Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medicus Stock Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.